Sophie Dimicoli

Toll-like receptor alterations in myelodysplastic syndrome

Yue Wei, Sophie Dimicoli, Carlos E. Bueso‐Ramos et al. · Leukemia · 2013 · 160 citations

Life Sciences, Immunology, Molecular Biology +12

Tumour lysis syndrome and acute kidney injury in high‐risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en <scp>R</scp>éanimation Respiratoire et <scp>O</scp>nco‐<scp>H</scp>ématologique

Michaël Darmon, François Vincent, Laurent Camous et al. · British Journal of Haematology · 2013 · 109 citations

Medicine, Hematology, Oncology +14

Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells

Yue Wei, R Chen, Sophie Dimicoli et al. · Leukemia · 2013 · 87 citations

Life Sciences, Molecular Biology, Molecular Genetics +9

Overexpression of the Toll-Like Receptor (TLR) Signaling Adaptor MYD88, but Lack of Genetic Mutation, in Myelodysplastic Syndromes

Sophie Dimicoli, Yue Wei, Carlos E. Bueso‐Ramos et al. · PLoS ONE · 2013 · 71 citations · Full text

Life Sciences, Immunology, Pathology +17

Daclizumab, an efficient treatment for steroid‐refractory acute graft‐<i>versus</i>‐host disease

Pierre Bordigoni, Sophie Dimicoli, Laurence Clément et al. · British Journal of Haematology · 2006 · 57 citations

Life Sciences, Immunology, Pharmacotherapy +13